FHTX Logo

Foghorn Therapeutics Inc. (FHTX) 

NASDAQ
Market Cap
$425.29M
Sector
Healthcare
Industry
Biotechnology
Rank in Sector
673 of 968
Rank in Industry
376 of 556

Largest Insider Buys in Sector

FHTX Stock Price History Chart

FHTX Stock Performance

About Foghorn Therapeutics Inc.

Foghorn Therapeutics Inc., a clinical-stage biopharmaceutical company, discovers and develops medicines targeting genetically determined dependencies within the chromatin regulatory system. The company uses its proprietary Gene Traffic Control platform to identify, validate, and potentially drug targets within the system. It is developing FHD-286, a small molecule inhibitor of the enzymatic activity of BRG1 and BRM for the treatment of metastatic uveal melanoma and relapsed and/or refractory acute myeloid leukemia and myelodysplastic syndrome; and FHD-609, a small molecule protein degrader for BRD9 to treat patients with synovial sarcoma. The company is also developing an enzymatic inhibitor and a protein degrader as selective modulators of BRM; and ARID1B selective modulators for the treatment of ovarian, endometrial, colorectal, bladder, and gastric cancers. It has a research collaboration and license agreement with Merck Sharp & Dohme Corp. to discover and develop novel oncology therapeutics against a transcription factor target; and with Loxo Oncology to create novel oncology medicines. Foghorn Therapeutics Inc. was incorporated in 2015 and is headquartered in Cambridge, Massachusetts.

Insider Activity of Foghorn Therapeutics Inc.

Over the last 12 months, insiders at Foghorn Therapeutics Inc. have bought $0 and sold $853,289 worth of Foghorn Therapeutics Inc. stock.

On average, over the past 5 years, insiders at Foghorn Therapeutics Inc. have bought $4.89M and sold $1.71M worth of stock each year.

There was no buying activity among insiders over the last 12 months.

The last purchase of 150,000 shares for transaction amount of $2.4M was made by Flagship Ventures Fund V General Partner LLC (10 percent owner) on 2020‑10‑27.

List of Insider Buy and Sell Transactions, Foghorn Therapeutics Inc.

2024-09-23SaleChief People Officer
857
0.0017%
$10.17$8,716-15.24%
2024-09-20SaleChief People Officer
35,756
0.0649%
$10.04$358,990-20.47%
2024-09-18SaleChief People Officer
11,574
0.022%
$10.05$116,319-16.32%
2024-09-17SaleChief People Officer
10,272
0.0189%
$10.04$103,131-18.60%
2024-09-16SaleChief People Officer
400
0.0008%
$10.00$4,000-13.39%
2024-09-09SaleChief Scientific Officer
20,000
0.0366%
$9.50$190,000-13.82%
2024-03-11SaleChief Strategy/Bus Ops Officer
11,000
0.0249%
$6.56$72,134-2.91%
2023-08-16SaleChief Medical Officer
311,297
0.6823%
$8.25$2.57M-35.39%
2020-10-27Purchase10 percent owner
150,000
1.3579%
$16.00$2.4M-20.50%
2020-10-27Purchase
150,000
1.3579%
$16.00$2.4M-20.50%
2020-10-27PurchaseChief Scientific Officer
5,500
0.0498%
$16.00$88,000-20.50%

Insider Historical Profitability

<0.0001%
Bellon Steven F.Chief Scientific Officer
101957
0.1834%
$7.6501
Cavalie FannyChief Strategy/Bus Ops Officer
75992
0.1367%
$7.6501
Costa CarlosChief People Officer
0
0%
$7.6505
Flagship Ventures Fund V General Partner LLC10 percent owner
9330878
16.7842%
$7.6510<0.0001%
Abu Dhabi Investment Authority
1231081
2.2144%
$7.6510<0.0001%
DECICCO CARLChief Scientific Officer
258397
0.4648%
$7.6510<0.0001%
Agresta SamuelChief Medical Officer
0
0%
$7.6501

Institutional Investor Ownership

Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
Flagship Pioneering$85.04M22.9112.67M0%+$05.58
Fidelity Investments$18.06M4.862.69M-4.23%-$797,637.81<0.01
Raymond James Associates$14.97M4.032.23M+7.84%+$1.09M0.01
Euclidean Capital Llc$10.56M2.841.57M0%+$01.36
BlackRock$8.83M2.381.32M+0.73%+$63,765.13<0.0001
The Vanguard Group$7.4M1.991.1M+7.55%+$519,219.73<0.0001
Artal Group S A$4.84M1.3720,7200%+$00.02
Alphabet$3.36M0.91500,9010%+$00.03
Geode Capital Management$3.01M0.81448,411+0.01%+$409.36<0.0001
State Street$2.94M0.79437,664+3.56%+$100,878.13<0.0001
Point72 Asset Management$2.93M0.79437,369-19.01%-$688,654.01<0.01
Birchview Capital Lp$2.15M0.58320,9300%+$00.12
Driehaus Capital Management LLC$1.88M0.51280,382-18.43%-$424,997.930.02
Jacobs Levy Equity Management$1.45M0.39216,270+101.05%+$729,377.150.01
Northern Trust$1.31M0.35195,242-2.02%-$27,054.72<0.0001
Sio Capital Management LLC$816,419.000.22121,6720%+$00.29
Panagora$673,047.000.18100,305+3.39%+$22,062.49<0.01
Morgan Stanley$503,049.000.1474,970-28.68%-$202,259.65<0.0001
Millennium Management LLC$416,335.000.1162,047New+$416,335.00<0.0001
BNY Mellon$407,761.000.1160,769+6.24%+$23,961.47<0.0001
Invesco$376,042.000.156,042New+$376,042.00<0.0001
Charles Schwab$372,016.000.155,4420%+$0<0.0001
Nuveen$362,092.000.153,9630%+$0<0.0001
Exchange Traded Concepts, LLC$316,021.000.0947,097+118.7%+$171,521.090.01
Baker Bros Advisors LP$302,131.000.0845,0270%+$0<0.01
Acadian Asset Management$283,000.000.0842,367New+$283,000.00<0.01
Marshall Wace$245,089.000.0736,526New+$245,089.00<0.0001
ALTA WEALTH ADVISORS$201,515.000.0530,0320%+$00.1
RhumbLine Advisers$179,411.000.0526,739+3%+$5,220.16<0.0001
Cornercap Investment Counsel Inc$173,245.000.0525,8190%+$00.03
Citadel Advisors LLC$160,859.000.0423,973New+$160,859.00<0.0001
Gsa Capital Partners Llp$147,000.000.0421,855-47.08%-$130,756.350.01
UBS$136,709.000.0420,374-12.86%-$20,176.89<0.0001
Barclays$129,000.000.0419,242-41.52%-$91,591.21<0.0001
Susquehanna International Group$107,897.000.0316,080+41.91%+$31,865.85<0.0001
HSBC$105,958.000.0315,791+16.21%+$14,782.18<0.0001
JPMorgan Chase$94,196.000.0314,038+6.54%+$5,784.08<0.0001
Xtx Topco Ltd$90,236.000.0213,448New+$90,236.00<0.01
State Board of Administration of Florida$77,339.000.0212,474New+$77,339.00<0.0001
Bank of America$85,406.000.0212,728-56.22%-$109,676.39<0.0001
Goldman Sachs$76,635.000.0211,421-19.8%-$18,922.22<0.0001
Fiduciary Trust Co$72,998.000.0210,8790%+$0<0.01
American International Group$67,221.000.0210,018-0.85%-$577.06<0.0001
AllianceBernstein$67,436.000.0210,0500%+$0<0.0001
Deutsche Bank$64,376.000.029,594-3.99%-$2,677.30<0.0001
Royal Bank of Canada$57,000.000.028,448+29.95%+$13,136.72<0.0001
Wells Fargo$40,790.000.016,079+15.44%+$5,455.22<0.0001
NISA Investment Advisors, LLC$33,577.000.015,004+0.08%+$26.84<0.0001
Citigroup$22,714.000.013,385+15.41%+$3,033.01<0.0001
New York State Common Retirement Fund$16,000.00<0.012,422+28.69%+$3,567.30<0.0001
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.